Covid-19 in Pharmaceutical and Biomedical Research

The novel coronavirus SARS-CoV-2 (COVID-19) is a global crisis leading to huge number of economic losses, morbidity, and mortality. This emerging infectious disease has significant implications for clinical and public health medical directors and their laboratories.

The journal of Pharmaceutical and Biomedical Research (PBR) has intended to publish a special issue of the articles related to COVID-١٩. We welcome all submissions of manuscripts related to any aspect of COVID-١٩. The topics of this special issue include diagnosis, characterization, pharmacological treatment, and epidemiology of COVID-١٩.

We also, encourage all COVID-١٩ related submissions and will provide authors with a fast track reviewing process within one week then accelerate online publication process of accepted manuscripts as soon as possible.

http://pbr.mazums.ac.ir/page/127/Call-for-Paper-POINTS--Special-Issue-on-COVID-19-Pandemic

More Amirhossein Ahmadi's questions See All
Similar questions and discussions